Special diet with standard therapy for rectal cancer
Part of Cancer, Digestive system clinical trials.
This trial tests a special medical food that limits certain amino acids (building blocks of protein) during standard treatment for rectal cancer. The goal is to see if this diet helps the treatment work better while reducing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of rectal adenocarcinoma (a type of rectal cancer).
- Your cancer should be stage II or III, meaning it has spread to nearby lymph nodes or is growing into the muscle layer of the rectum.
- You must be able to have surgery to remove the rectum (total mesorectal excision).
- The cancer must not have spread to other parts of the body (no distant metastases).
- You cannot have had chemotherapy or radiation therapy to the pelvis before.
- Your body mass index (BMI) must be between 18.5 and 40, and you cannot have insulin-dependent diabetes, serious weight loss, or a history of food allergies.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of a special diet supplement (beta-hydroxybutyrate), short radiation therapy, immunotherapy, and chemotherapy before surgery for locally advanced rectal cancer. The goal is to see if this approach helps shrink the tumor and improve treatment outcomes.
This trial studies whether a very low-carbohydrate (ketogenic) diet can be followed safely while you receive neoadjuvant radiation for locally advanced rectal cancer. It may help researchers understand effects related to nutrition and treatment tolerance during radiation.
This trial tests whether adding a new immunotherapy drug (cadonilimab) to standard chemoradiation before surgery helps patients with locally advanced rectal cancer. It aims to improve treatment outcomes by using a shorter course of radiation followed by a combination of the immunotherapy and chemotherapy.
This trial tests whether avoiding arginine (a protein building block) in the diet during chemoradiation can make the tumor shrink more before surgery for locally advanced rectal cancer. It may help reduce side effects and improve surgical outcomes.
This study tests a new treatment for locally advanced rectal cancer that combines an immunotherapy drug (PD-1 inhibitor) with a ketogenic diet and/or vitamin C. The goal is to see if this combination helps shrink tumors before surgery.
This study tests whether a special medical nutrition (a drink/food meant for people who need medical nutrition) given around the time of surgery helps patients with gastrointestinal cancer recover better. It aims to see if this nutrition approach is safe and beneficial when cancer is being removed.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.